The main goal of this study was to examine the effects of Botulinium Toxin-A in relieving symptoms of patients with perennial allergic rhinitis, who have been treated with antihistamines and corticosteroids for the past three years, but no recovery obtained.
40 male and female patients, between ages 20-40 years from clinics of (Pasargad; Karimkhan; Saee and the University of Social Welfare and Rehabilitation Sciences), based on inclusion ( chronic allergic rhinitis for the past three years ;Have not been cured with above mentioned medications ) and exclusion criteria (chronic sinusitis; asthma and or having other diseases), were selected.
Prior to interventions, research goals discussed, informed consents obtained voluntarily and then patients got divided randomly into two intervention (n=20) and control (n=20) groups.
The intervention group received 100 IU of Botulinium Toxin-A, mixed with nasal tampons(10 cm) and control group with the same method, but tampons mixed with Normal Saline which remained in their intranasal cavities for 30 minutes. Both groups were not aware of their type of treatments.
Symptoms assessed via a pre-designed, closed- questionnaire charts for itching (eyes, ears and nose); sneeze and rhinorrhea, which all graded from intervals of no symptoms (0) to sever (10). Scores collected in both groups for analysis in pre and post- intervention periods of (1, 3, 6 and 12 weeks) for analysis.